MedTrace Logo

Hyperglycemia in a Coronary Intensive Care Unit

NCT00984737 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2009-09-25

No results posted yet for this study

Summary

Newly diagnosed hyperglycemia (NDH) and stress hyperglycemia (SH) during acute illness is reported as a non-physiological condition in hospitals. The investigators aim is to determine the rate of NDH and SH among cases admitted to coronary ICU with acute coronary disease and to inquire the relationship of SH with disease severity and functional outcomes such as longevity of ICU stay.

Conditions

Interventions

DRUG

Insulin

Capillary glucose measurements of Group 2 and Group 3 will be performed during hospitalization and will be treated when they are over 180mg/dl. Short acting oral anti-diabetic drugs will be given to patients who refuse insulin injection.

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Study Design

Purpose
DIAGNOSTIC

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2008-11-30
Completion
2008-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00984737 on ClinicalTrials.gov